Tue.May 21, 2024

article thumbnail

AstraZeneca, on fast track of growth, sets revenue target at $80B by 2030

Fierce Pharma

A decade ago, with AstraZeneca in decline and some investors urging the drugmaker to sell out to Pfizer, new CEO Pascal Soriot presented an audacious plan to hike revenue to $45 billion by 2023. | After AstraZeneca achieved Pascal Soriot's ambitious $45-billion-by-2023 revenue goal, the CEO is thinking big again. On Tuesday morning, AZ unveiled its new plan to swell its revenue to $80 billion by 2030.

306
306
article thumbnail

Why Healthcare Data Is Vital for Employers

MedCity News

Employers need healthcare data in order to make decisions, but the data isn’t always easy to get, experts said on a panel at MedCity INVEST. The post Why Healthcare Data Is Vital for Employers appeared first on MedCity News.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Incyte plots Delaware expansion as it looks to re-wed commercial, medical teams in its home state

Fierce Pharma

As Incyte Corporation continues its growth momentum thanks to JAK inhibitors Jakafi and Opzelura, the company is bringing its U.S. | Incyte revealed plans to purchase buildings at 1100 North King Street and 1100 North French street in downtown Wilmington, Delaware, where the company got its start back in 2002.

Medical 273
article thumbnail

Introducing the Clarivate Academic AI Platform

Clarivate

We have released the first version of the Clarivate Academic AI Platform, serving our suite of AI-powered Research Assistants. Discover how it is going to help address the needs of students, researchers and librarians for trusted AI. At Clarivate TM , we understand the transformative power of artificial intelligence (AI) in the academic realm and the imperative to introduce AI thoughtfully and responsibly into research, teaching and learning environments.

article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Lilly pads case for mirikizumab in its next potential indication in Crohn's disease

Fierce Pharma

Following last year’s hard-won ulcerative colitis nod for Eli Lilly’s Omvoh, also known as mirikizumab, the Indianapolis-based drugmaker is padding the case for its antibody’s next potential immuno | Following last year’s hard-won ulcerative colitis nod for Eli Lilly’s Omvoh, also known as mirikizumab, the Indianapolis-based drugmaker is padding the case for its antibody’s next potential immunology approval.

264
264
article thumbnail

4 Things Digital Health Investors Need To Get Off Their Chest

MedCity News

During a panel at MedCity News’ INVEST conference, venture capitalists shared some of their takes on today’s healthcare funding landscape — including their thoughts on AI and the industry’s slower investment pace. The post 4 Things Digital Health Investors Need To Get Off Their Chest appeared first on MedCity News.

More Trending

article thumbnail

5 Things to Know About How NIH’s SEED Can Help Life Science Startups Grow

MedCity News

The NIH’s SEED office formed to help startups leverage government’s funding programs. Chris Sasiela, director of the SEED office, discussed these programs during the MedCity News INVEST Conference in Chicago. The post 5 Things to Know About How NIH’s SEED Can Help Life Science Startups Grow appeared first on MedCity News.

Biopharma 126
article thumbnail

AstraZeneca sets lofty target of $80bn in revenues by 2030

pharmaphorum

AstraZeneca CEO Pascal Soriot says group revenues can reach $80bn by 2030, fuelled by a pipeline that features 'many' potential $5bn-plus candidates.

119
119
article thumbnail

3 up-and-coming US biotech hotspots

PharmaVoice

These three U.S. cities are putting themselves on the biotech map as unsung hubs of the industry.

116
116
article thumbnail

FDA competition seeks digital endpoints for Parkinson’s

pharmaphorum

FDA is asking artificial intelligence teams to develop a digital endpoint tool to study freezing of gait, a symptom of Parkinson’s that can have a serious impact on patients.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Importance of Patient Capital in Life Sciences

MedCity News

The TSX Venture Exchange has a strong history of helping early-stage health and life sciences companies raise patient capital for research and development. The post Importance of Patient Capital in Life Sciences appeared first on MedCity News.

Patients 110
article thumbnail

EU rules PTC’s Duchenne drug can stay on the market

pharmaphorum

Going against the advice of the CHMP, the EU has said that PTC Therapeutics’ Translarna therapy for Duchenne muscular dystrophy should stay on the market

Marketing 105
article thumbnail

FOCUS ON: Connected TV

PM360

PM360’s Focus On section examines a specific area of the life sciences industry. In this issue, we take a closer look at the evolution of the Smart TV and the increase of streaming services and how they can benefit the pharma industry. From connecting with patients by interactive ads to dabbling into cross-platform integration, here is what our specialists had to say.

Media 105
article thumbnail

Novel biologic could offer ulcerative colitis symptomatic remission

European Pharmaceutical Review

Initial data from a Phase III maintenance study of TREMFYA ® (guselkumab) has demonstrated promising remission rates obtained from a dual-acting monoclonal antibody given to ulcerative colitis (UC) patients. This data from Johnson & Johnson’s Phase III QUASAR study is being presented at Digestive Disease Week 2024 (Abstract #759). Achievement of clinical remission Fifty percent of patients with moderate to severe active ulcerative colitis given subcutaneous TREMFYA (guselkumab) 200mg every f

Patients 105
article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

Internal budgets ‘holding back pharma’s digital evolution’

pharmaphorum

Digital investment in the pharma sector is continuing at a steady pace but could fall behind what is needed to deliver true transformation of their businesses.

Pharma 102
article thumbnail

Pharma Pulse 5/21/24: Hims & Hers Announces Access to GLP-1 Injections, The Impact of the Presidential Election on Pharma & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

Pharma 99
article thumbnail

Roche’s PI3K inhibitor secures breakthrough status in breast cancer

Pharmaceutical Technology

Roche announced an FDA breakthrough therapy designation for its inavolisib/Ibrance combination therapy.

FDA 98
article thumbnail

The Power of Grip: A Journey from Adversity to Success in the Consumer Goods Industry

Scott Burrows

In the world of motivational speaking, stories of triumph over adversity are not uncommon. But for me, the narrative goes beyond inspiration—it’s about embodying the very principles of vision, mindset, and grit that have shaped my journey. At the age of 19, a car accident left me with a broken neck and a daunting diagnosis of quadriplegia. But from the confines of a wheelchair, I refused to let my circumstances define me.

article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

NIHR awards HealthTech Research Centre Network £5m to advance health innovations

PharmaTimes

The network will support the development, evaluation and adoption of innovative health and care technology

article thumbnail

Effects of the Federal Trade Commission's Repeal of Non-Compete Agreements on the Pharma Industry

Pharmaceutical Commerce

In an interview with Pharma Commerce Associate Editor Don Tracy, Ron Lanton, Partner, Lanton Law offers his thoughts on the recent Federal Trade Commission (FTC) repeal of non-compete agreements, and how it could effect the pharma industry.

Pharma 81
article thumbnail

NHS addresses shortage of ethnic organ and blood donors with £600,000 funding

PharmaTimes

The funding aims to reduce health inequalities in these groups and save more lives

92
article thumbnail

A Modular Approach to Personalized Engagement

PM360

A well-oiled modular content engine lets manufacturers engage customers and differentiate their product beyond the label. By Matthew Smith Over the past few years, the life sciences industry has seen an increase in ways to engage with customers at different touchpoints. During the COVID-19 pandemic, pharma organizations built new digital and virtual channels to communicate with healthcare providers (HCPs) outside of their offices.

article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

FDA Grants Breakthrough Therapy Designation to Inavolisib for PIK3CA-Mutated Breast Cancer

Pharmacy Times

Inavolisib was submitted to the FDA for review as a first-line treatment for advanced HR-positive, HER2-negative PIK3CA-mutated breast cancer.

FDA 58
article thumbnail

The Diverse Roles of Nurse Practitioners in Modern Healthcare

Scott’s Directories

The landscape of healthcare is constantly evolving. As the demand for accessible, high-quality care grows, new approaches and roles are emerging to meet these critical needs. Nurse practitioners (NPs) have become a cornerstone of this transformation, providing patients with comprehensive, personalized care. However, finding qualified NPs can sometimes feel like a daunting task.

article thumbnail

Program Highlights Opportunities for Community Pharmacies to Deliver Screening, Education, and Referral Interventions

Pharmacy Times

Aligning community pharmacy interventions with top-down findings, payers’ population health priorities, and identified unmet needs can help develop a sustainable pathway.

article thumbnail

IndustryBRIEFS

PM360

EVERSANA and MyHealthTeam collaborate to help patients connect more quickly on social media regarding diagnosis and treatment. EVERSANA and MyHealthTeam Collaborate to Launch Direct-to-Patient Solution EVERSANA and MyHealthTeam announced that they have joined forces to help life sciences companies use the power of Artificial Intelligence (AI) and accelerate the time to diagnosis and treatment for millions of patients all over the world.

Media 52
article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Study Supports Pharmacists’ Roles in Ensuring Appropriate Use of Oral Oncolytics

Pharmacy Times

As value-based health care models become more widespread, these types of interventions will be important to demonstrate the value of pharmacist-embedded HSSPs.

57
article thumbnail

Changing the Conversation About Women in Pharma

PM360

Gender imbalance was so ingrained in me as I grew up that, even as a woman, I have at times in my career been gender- blind. I was lucky enough to enter academia with a number of women colleagues. It was only later in my career that I started noticing the gender gap in the pharma industry. Minding the Gap In 2012, I was invited to a life science and pharma event in London as part of the Olympics.

Pharma 52
article thumbnail

Advancement in CAR T Cell Therapy for Patients with Multiple Myeloma Helps Predict Treatment Response and Resistance

Pharmacy Times

Researchers from the University of Leipzig Medical Center identify multiple biomarkers associated with the success of CAR T cell therapy in relapsed multiple myeloma.

article thumbnail

Driving Adherence with AI—Possibilities and Guardrails

PM360

From 19th century fiction like Pinocchio to modern science fiction like Star Trek, Artificial Intelligence (AI) has intrigued us with existential dilemmas and life-changing potential. It is unsurprising then that AI’s arrival has impacted Life Sciences so profoundly. AI has driven major advances across the Life Sciences value chain from molecule discovery to clinical trials to manufacturing.

Medical 52
article thumbnail

Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A